SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000881464-12-000006
Filing Date
2012-05-07
Accepted
2012-05-07 08:56:18
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q amln201233110q.htm 10-Q 972449
2 PROJECT AGREEMENT AND MASTER SERVICE AGREEMENT amlnexhibit101.htm EX-10.1 219609
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER amlnexhibit311.htm EX-31.1 11950
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER amlnexhibit312.htm EX-31.2 12145
5 CERTIFICATIONS PURSUANT TO U.S.C. SECTION 1350 amlnexhibit321.htm EX-32.1 6703
  Complete submission text file 0000881464-12-000006.txt   7629575

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amln-20120331.xml EX-101.INS 1222231
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amln-20120331.xsd EX-101.SCH 58437
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amln-20120331_cal.xml EX-101.CAL 88247
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amln-20120331_def.xml EX-101.DEF 197851
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amln-20120331_lab.xml EX-101.LAB 601459
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amln-20120331_pre.xml EX-101.PRE 339377
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 12816039
SIC: 2834 Pharmaceutical Preparations